Periodontal Health and Its Impact on Oral Health-related Quality of Life Among Diabetes Mellitus Patients
NCT ID: NCT06125561
Last Updated: 2023-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2023-10-01
2023-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodontal Treatment and Glycemic Control
NCT01901926
Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
NCT03343366
Effectiveness of Periodontal Treatment for the Glycemic Conttrol of Type II Diabetes Mellitus
NCT05587413
Periodontal Follow-up and Glycemy in Patients With Type 2 Diabetes
NCT07165171
Effect of Non-surgical Periodontal Treatment on HbA1c in Type 2 Diabetic Patients
NCT02652026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic
Diabetic patients with age ranges 18-60 years. Clinical Examination will be performed by CPTIN probe and questionnaire will be filled by participant's.
Probing depth and Clinical attachment loss
CPTIN probe will be used for the clinical examination
Non diabetic
Non Diabetic patients with age ranges 18-60 years. Clinical Examination will be performed by CPTIN probe and questionnaire will be filled by participant's.
Probing depth and Clinical attachment loss
CPTIN probe will be used for the clinical examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probing depth and Clinical attachment loss
CPTIN probe will be used for the clinical examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pakistan Institute of Medical Sciences
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
nosheen sarwar
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PIMS
Islamabad, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14112023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.